Ichiro Takata

发表

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Masahiro Fukuoka, Yutaka Nishiwaki, Danny Rischin, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Focal ground-glass opacity detected by low-dose helical CT.

Kenji Eguchi, Masao Nakata, K. Eguchi, 2002, Chest.

Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.

Keitaro Matsuo, Masahiro Tabata, Susumu Kanazawa, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.